CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 302 enrolled
Drug / intervention
enVista Toric +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05075746
NCT05075746N/ACompleted

Retrospective Chart Review of enVista Toric 0.9D Intraocular Lenses

Bausch & Lomb Incorporated·observational·Posted Oct 13, 2021·Updated Mar 27, 2024

In Brief

An observational study evaluating enVista Toric and enVista non-Toric (spherical) for Corneal Astigmatism. Completed, enrolled 302 participants across 3 sites.

Detailed Summary

The primary objective of this study is to evaluate the performance of the enVista Toric 0.9D vs non-Toric IOL.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesCanada
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedOct 13, 2021
Enrollment StartMar 8, 2022
Primary CompletionJan 3, 2023
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 4.7 years ago

Interventions

enVista Toricdevice

enVista Toric IOL

enVista non-Toric (spherical)device

enVista non-Toric (spherical) IOL